Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
Ipsen Foundation Symposium
Connections, Cognition And Alzheimer's Disease

Alzheimer changes in hypothalmic nuclei: Their relationship to neuronal activity and clinical symptoms.

By D.F. Swaab, P.J. Lucassen, J.A.P. van de Nes, R. Ravid and A. Salehi

Graduate School Neurosciences Amsterdam, Netherlands Institute for Brain Research, Meibergdreef 33, 1105 AZ Amsterdam, The Netherlands

ABSTRACT

The neuropathological hallmarks of Alzheimer's disease (AD), i.e. amorphous plaques, senile plaques (SPs), pretangles, neurofibrillary tangles (NFT) and cell death are not part of a pathogenetic cascade but are basically independent phenomena. Pretangles can occur in neurons from which the metabolic rate is not altered. However, in brain areas where classical AD changes, i.e. SPs and NFT are present such as the CA1 area of the hippocampus, the nucleus basalis of Meynert and the tuberomamillary nucleus, a decreased metabolic rate is found.

Decreased metabolic rate also seems to be an independent phenomenon in Alzheimer's disease. It is not induced by the presence of pretangles, NFT or SPs. Decreased metabolic rate is considered to be crucial and an early occurring hallmark of Alzheimer's disease. In theory, decreased metabolic rate may be reversible. It is, therefore, attractive to direct the development of therapeutic strategies towards restimulation of neuronal metabolic rate in order to improve cognition and other symptoms in Alzheimer's disease.

Index of Slides

Alz-50 staining of nucleus tuberalis lateralis. Pre-tangle pathology without amyloid.

Golgi staining of nucleus basalis of Meynert. Evidence of neuronal inactivity.

Graph: Loss of neuronal activity in Alzheimer patients.

Decreased activity in tuberomamillary nucleus in AD. [Text only]

Paraventricular nucleus and the supraoptic nucleus don't show AD changes. [Text only]

No relation between decreased Golgi and plaques. [Text only]

Loss of Trk receptors in AD patients. [Text only]

Light-induced plasticity of suprachiasmic nucleus in AD patients. [Text only]

Conclusions



Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad